Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Myasthenia Gravis Foundation of America Global MG Patient Registry
for
Myasthaenia Gravis, Myasthenia,
Location: Westborough MA
Sponsor: Myasthenia Gravis Foundation of America
Sex: All
Age: 18+
Code: NCT06617741
Recruiting
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Intermediate Risk Prostate Cancer, High Risk Prostate Cancer,
Location: Milford MA, Weymouth MA
Sponsor: Martin T. King, MD, PhD
Sex: Male
Age: 18+
Code: NCT07393867
Phase 2, Recruiting
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
for
Glioblastoma (GBM)
Location: Milford MA, Boston MA, South Weymouth MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 65+
Code: NCT06835803
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: Milford MA, Foxborough MA, Springfield MA, Methuen MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase 2, Recruiting
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
for
Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative
Location: Milford MA, Foxborough MA, Boston MA, South Weymouth MA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04468061
Phase 2, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Milford MA, Foxborough MA, Boston MA, Providence RI,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for
Breast Cancer, HER2-positive Breast Cancer
Location: Milford MA, Newton MA, Foxborough MA, Brighton MA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04893109
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Milford MA, Boston MA, South Weymouth MA, Sanford ME,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Milford MA, Foxborough MA, Brighton MA, Boston MA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase 2, Phase 3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Milford MA, Foxborough MA, Brighton MA, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase 3, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Milford MA, Robbinsville NJ, Philadelphia PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 12 - 17
Code: NCT06979453
Phase 3, Recruiting
Optimize Pattern Recognition Control of Powered Upper Limb Prosthesis